statistiche ricercatore

Continente	#
NA - Nord America	706
AS - Asia	491
EU - Europa	358
SA - Sud America	90
Continente sconosciuto - Info sul continente non disponibili	18
AF - Africa	12
OC - Oceania	4
Totale	1.679

Nazione	#
US - Stati Uniti d'America	659
SG - Singapore	224
CN - Cina	112
IT - Italia	97
BR - Brasile	71
IE - Irlanda	54
FR - Francia	41
VN - Vietnam	38
DE - Germania	37
GB - Regno Unito	28
BD - Bangladesh	27
CA - Canada	25
SE - Svezia	24
IN - India	20
FI - Finlandia	18
JP - Giappone	17
KR - Corea	14
ID - Indonesia	13
AR - Argentina	11
ES - Italia	9
PL - Polonia	9
RU - Federazione Russa	8
MK - Macedonia	7
MX - Messico	7
HK - Hong Kong	6
CO - Colombia	5
NL - Olanda	5
CZ - Repubblica Ceca	4
BE - Belgio	3
IQ - Iraq	3
MA - Marocco	3
PA - Panama	3
PH - Filippine	3
TR - Turchia	3
AU - Australia	2
CH - Svizzera	2
CI - Costa d'Avorio	2
DZ - Algeria	2
EC - Ecuador	2
GP - Guadalupe	2
GT - Guatemala	2
IL - Israele	2
LT - Lituania	2
LV - Lettonia	2
NZ - Nuova Zelanda	2
RO - Romania	2
TT - Trinidad e Tobago	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BZ - Belize	1
CW - ???statistics.table.value.countryCode.CW???	1
CY - Cipro	1
DO - Repubblica Dominicana	1
HN - Honduras	1
HR - Croazia	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
LY - Libia	1
NP - Nepal	1
PK - Pakistan	1
PR - Porto Rico	1
PY - Paraguay	1
RS - Serbia	1
SC - Seychelles	1
SN - Senegal	1
SV - El Salvador	1
TH - Thailandia	1
UA - Ucraina	1
ZA - Sudafrica	1
Totale	1.662

Nome	#
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial	204
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey	192
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey	155
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls	148
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey	143
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy	140
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?	134
Genetic modifiers of upper limb function in Duchenne muscular dystrophy	128
An observational study of functional abilities in infants, children, and adults with type 1 SMA	126
Risdiplam in Type 1 Spinal Muscular Atrophy	119
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey	107
Genotype-phenotype correlations in recessive titinopathies	83
Totale	1.679

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	110	0	4	10	15	2	12	13	17	20	5	6	6
2023/2024	162	7	31	9	13	6	24	13	9	7	9	21	13
2024/2025	275	4	2	21	9	34	20	12	10	27	16	68	52
2025/2026	930	94	33	67	152	170	49	133	45	38	74	38	37
2026/2027	202	13	44	32	94	19	0	0	0	0	0	0	0
Totale													1.679

IRIS UniCatt